Rockwell Medical Inc Cash Flow Conversion Efficiency

Latest as of June 2026: 0.059x

Rockwell Medical Inc cash flow conversion efficiency. Based on the latest financial reports, Rockwell Medical Inc (RMTI) has a cash flow conversion efficiency ratio of 0.059x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.08 Million) by net assets ($35.09 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Rockwell Medical Inc (1997–2025)

Cash flow conversion efficiency of Rockwell Medical Inc from 1997 to 2025. This chart illustrates how Rockwell Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Rockwell Medical Inc stock price today for real-time trading data and today's change.

Rockwell Medical Inc Cash Flow Conversion Ratio Explained

Rockwell Medical Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Rockwell Medical Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Rockwell Medical Inc ranked by their cash flow conversion efficiency. Also see Rockwell Medical Inc market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Health In Tech, Inc. Class A Common Stock
NASDAQ:HIT
-0.154x
PTRB
KLSE:0260
0.084x
Gome Telecom Equipment Co Ltd
SHG:600898
-0.051x
Globrands Group Ltd
TA:GLRS
0.902x
Xu Yuan Packaging Technology Co Ltd
TWO:8421
-0.026x
Auctus Alternative Investments Ltd
AU:AVC
0.026x
Quince Therapeutics, Inc.
NASDAQ:QNCX
-0.174x
Euro Holdings Bhd
KLSE:7208
0.044x

Annual Cash Flow Conversion Efficiency for Rockwell Medical Inc (1997–2025)

The table below shows the annual cash flow conversion efficiency of Rockwell Medical Inc from 1997 to 2025. Review Rockwell Medical Inc (RMTI) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $36.98 Million $-659.00K -0.018x -113.82%
2024-12-31 $32.59 Million $4.20 Million 0.129x +129.17%
2023-12-31 $21.29 Million $-9.41 Million -0.442x +63.17%
2022-12-31 $14.11 Million $-16.93 Million -1.200x +90.93%
2021-12-31 $2.54 Million $-33.53 Million -13.228x -1424.96%
2020-12-31 $34.17 Million $-29.64 Million -0.867x +35.33%
2019-12-31 $20.32 Million $-27.25 Million -1.341x -79.17%
2018-12-31 $27.28 Million $-20.42 Million -0.749x -16.70%
2017-12-31 $32.91 Million $-21.11 Million -0.642x -172.81%
2016-12-31 $52.96 Million $-12.45 Million -0.235x +9.77%
2015-12-31 $62.32 Million $-16.24 Million -0.261x -520.51%
2014-12-31 $68.70 Million $4.26 Million 0.062x +100.07%
2013-12-31 $595.54K $-50.66 Million -85.074x -2856.37%
2012-12-31 $-9.96 Million $-30.75 Million 3.086x +622.23%
2011-12-31 $18.24 Million $-10.78 Million -0.591x -959.08%
2010-12-31 $30.54 Million $2.10 Million 0.069x +241.39%
2009-12-31 $29.32 Million $-1.43 Million -0.049x +86.53%
2008-12-31 $11.82 Million $-4.27 Million -0.361x -90.83%
2007-12-31 $17.96 Million $-3.40 Million -0.189x +53.49%
2006-12-31 $8.37 Million $-3.41 Million -0.407x -216.96%
2005-12-31 $3.84 Million $-493.52K -0.128x -142.79%
2004-12-31 $3.42 Million $1.03 Million 0.300x +322.10%
2003-12-31 $3.17 Million $225.42K 0.071x +119.41%
2002-12-31 $3.05 Million $-1.12 Million -0.366x -3.36%
2001-12-31 $2.60 Million $-920.02K -0.354x -104.25%
2000-12-31 $2.86 Million $-496.35K -0.173x +30.61%
1999-12-31 $3.60 Million $-900.00K -0.250x +50.00%
1998-12-31 $4.60 Million $-2.30 Million -0.500x +29.17%
1997-12-31 $1.70 Million $-1.20 Million -0.706x --

About Rockwell Medical Inc

NASDAQ:RMTI USA Drug Manufacturers - Specialty & Generic
Market Cap
$31.93 Million
Market Cap Rank
#23449 Global
#5115 in USA
Share Price
$8.09
Change (1 day)
+17.08%
52-Week Range
$0.55 - $8.86
All Time High
$141.02
About

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate conce… Read more